Andrew Moreo

Head of Process Development • Andelyn Biosciences

Andrew Moreo, provides daily control as well as strategic guidance for the process development.  He ensures that all activities within the process development and preclinical manufacturing teams.  He ensures that all activities within the process development are within compliance standards.  Mr. Moreo has over 20 years of experience in genetic and molecular research. He has worked for RINCH for the past 13 years focusing on AAV including the development of the current AAV production platform.  Mr. Moreo has a BS in Biology from Purdue University

Also Speaking

Samarendra Mohanty

Co-Founder and President • Nanoscope Therapeutics

David Hodl

Head of Sales, Cell Therapy Custom and Configured Platforms • Invetech

Jeffrey Boyd

Partner, Global Healthcare & Life Sciences Practice • Heidrick & Struggles

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.